文献速递产科生殖医学

辅助生殖技术治疗在潜在不孕诊断基础上增加产科和新生儿风险

Assisted reproductive technology treatment increases obstetric and neonatal risks over that of the underlying infertility diagnosis.
PubMed 文献 · Fertil Steril · 2022-04-07

该回顾性研究基于马萨诸塞州2013-2017年关联数据,比较有或无输卵管疾病、多囊卵巢综合征(PCOS)、其他排卵状况或子宫内膜异位症诊断的单胎分娩者中辅助生殖技术(ART)与非ART的妊娠结局。结果显示不孕相关诊断本身增加妊娠高血压、子痫前期/子痫、妊娠期糖尿病和胎盘问题等风险,而在同一诊断内使用ART一致增加胎盘问题风险(aRR 1.49-2.86)。

要点

  • 不孕相关诊断(输卵管、PCOS、其他排卵、子宫内膜异位症)较 fertile 组增加妊娠高血压、子痫前期/子痫、妊娠期糖尿病、胎盘问题、低出生体重和早产风险。
  • 在同一诊断内,ART使用一致增加胎盘问题风险(aRR 1.49-2.86),其他疾病风险变化不一。
  • 与 fertile 组相比,有上述诊断且接受或未接受ART的妊娠和分娩风险均升高。

核心结论

  • 与 fertile 组相比,有输卵管、PCOS、其他排卵状况或子宫内膜异位症诊断且接受或未接受ART治疗的妊娠和分娩风险升高。
  • 在同一诊断内,ART分娩较非ART分娩的胎盘异常风险尤其升高。

研究设计与样本

  • 马萨诸塞州2013-2017年关联ART、出生证明、出院数据和门诊保险索赔数据的回顾性研究。
  • 研究对象为有或无输卵管疾病、PCOS、其他排卵状况或子宫内膜异位症诊断的单胎分娩者,诊断来自保险索赔和ART数据。
  • 采用泊松分布和可交换相关结构的广义估计方程获得校正相对风险比(aRR)和95%置信区间(CI)。

主要发现

  • 与 fertile 组相比,PCOS诊断增加妊娠高血压风险(aRR 1.13,95% CI 1.00-1.27)。
  • 与 fertile 组相比,输卵管诊断(aRR 1.28,95% CI 1.02-1.61)、PCOS(aRR 1.23,95% CI 1.06-1.43)和其他排卵状况(aRR 1.11,95% CI 1.02-1.20)增加子痫前期/子痫风险。
  • 与 fertile 组相比,输卵管诊断(aRR 1.28,95% CI 1.08-1.50)、PCOS(aRR 1.58,95% CI 1.42-1.75)和其他排卵状况(aRR 1.19,95% CI 1.12-1.26)增加妊娠期糖尿病风险。
  • 与 fertile 组相比,输卵管诊断增加胎盘问题风险(aRR 1.47,95% CI 1.11-1.94),并增加低出生体重和早产风险。
  • 在同一诊断内,ART使用一致增加胎盘问题风险(aRR 1.49-2.86),其他疾病风险变化不一。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether assisted reproductive technology (ART) treatment adds obstetric and neonatal risks over and above that of underlying infertility-related diagnoses. DESIGN: Retrospective study of linked ART, birth certificate, hospital discharge data, and outpatient insurance claims data in Massachusetts (2013-2017). SETTING: Database. PATIENT(S): Singleton deliveries in women with and without diagnoses of tubal disease, polycystic ovarian syndrome (PCOS), other ovulatory conditions, or endometriosis, identified from the insurance claims and ART data. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): ART and non-ART pregnancy and delivery outcomes were compared with each other and with women with no history of infertility or usage of fertility treatment (fertile group). Generalizing estimating equations with Poisson distribution and exchangeable correlation structure were used to obtain adjusted relative risk ratios (aRRs) and 95% confidence intervals (CIs). RESULT(S): Infertility-related diagnoses significantly increased the risks of pregnancy hypertension (PCOS: aRR, 1.13, 95% CI 1.00-1.27), preeclampsia/eclampsia (tubal: aRR 1.28, 95% CI 1.02-1.61; PCOS: aRR 1.23, 95% CI 1.06-1.43; other ovulatory: aRR 1.11, 95% CI 1.02-1.20), gestational diabetes (tubal: aRR 1.28, 95% CI 1.08-1.50; PCOS: aRR 1.58, 95% CI 1.42-1.75; other ovulatory: aRR 1.19, 95% CI 1.12-1.26), and placental problems (tubal aRR 1.47, 95% CI 1.11-1.94), as well as low birthweight and prematurity, compared with deliveries from the fertile group. Within each diagnosis, the use of ART consistently increased the risk of placental problems (aRR 1.49-2.86) but varied for other conditions. CONCLUSION(S): Our study demonstrated that compared with the fertile group, risk was elevated in pregnancies and deliveries from women with tubal, PCOS, other ovulatory, and endometriosis diagnoses who did/did not undergo ART treatment. Placental abnormalities were particularly elevated in ART compared to non-ART deliveries having the same diagnosis.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Stern JE, Liu CL, Cui X, et al. Assisted reproductive technology treatment increases obstetric and neonatal risks over that of the underlying infertility diagnosis. Fertil Steril. 2022. PMID: 35397876. doi:10.1016/j.fertnstert.2022.02.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。